BOSTON--(BUSINESS WIRE)--BAKX Therapeutics today announced it closed $25 million in a Series A fundraising led by AB Magnitude Ventures Group with Ipsen Pharma SA and Sherpa Healthcare Partners. The ...
Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today key clinical development progress, including the ...
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are ...
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are poorly understood.
American researchers have observed the process of cell self-destruction, or apoptosis, gaining insights into its velocity—an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results